SCHEMBL8620511

SCHEMBL8620511

CCCCCCCc1ccc(CCC(CS(=O)(=O)O)P(=O)(OCC)OCC)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 16/20 0.52
S1PR3 Q99500 13/20 0.52
S1PR2 O95136 10/20 0.52
S1PR4 O95977 9/20 0.50
ENPP2 Q13822 1/20 0.45
S1PR5 Q9H228 5/20 0.44
ESR1 P03372 2/20 0.40
ADRA2A P08913 2/20 0.40
ADORA3 P0DMS8 2/20 0.40
TACR2 P21452 2/20 0.40
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 2/20 0.40
SLC6A3 Q01959 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
SHBG P04278 1/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
HSPD1 P10809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8625399 0.88 POLB (0.42) S1PR1S1PR3S1PR2S1PR4KDM4E
SCHEMBL8618660 0.83 POLB (0.42) KDM4EALDH1A1LMNA
SCHEMBL8620506 0.81 S1PR1 (0.50) S1PR1S1PR3S1PR2S1PR4ENPP2
SCHEMBL8624041 0.81 FDFT1 (0.45) S1PR1
SCHEMBL8947010 0.78 S1PR1 (0.36) S1PR1S1PR3S1PR2S1PR4S1PR5
SCHEMBL8619659 0.78 EPHX2 (0.38)
SCHEMBL8659011 0.72 FDFT1 (0.56) S1PR1S1PR3S1PR2S1PR4
SCHEMBL8620192 0.70 FDFT1 (0.43) S1PR1S1PR3S1PR2S1PR4S1PR5
SCHEMBL8619754 0.70 FDFT1 (0.50) S1PR1S1PR3S1PR2S1PR4
SCHEMBL8620898 0.70 ENPP2 (0.60) S1PR1S1PR3S1PR2S1PR4ENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5712396-A PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS MAGNIN DAVID R (US) 1998-01-27 US disclosed
US-5567841-A ANTICHOLESTEROL AGENT BRISTOL-MYERS SQUIBB COMPANY (US) 1996-10-22 US disclosed
US-5470845-A Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-28 US disclosed